Web Images Videos Maps News Shopping Gmail more »
Help | Sign in
Go to Google Groups Home
   
Discussions for Novartis AG (ADR) View all discussions
My starred discussions
My profile

  FDA APPROVAL Diovan
All 4 messages in discussion  - 
Reporting discussion
Messages reported
The group you are posting to is a Usenet group. Messages posted to this group will make your email address visible to anyone on the Internet.
Your reply message has not been sent.
Your post was successful
 
From:
To:
Cc:
Followup To:
Add Cc | Add Followup-to | Edit Subject
Subject:
Validation:
For verification purposes please type the characters you see in the picture below or the numbers you hear by clicking the accessibility icon. Listen and type the numbers you hear
 
johnzakha...@gmail.com  
View profile  
(1 user)  More options Dec 3 2007, 4:03 pm
From: johnzakha...@gmail.com
Date: Mon, 3 Dec 2007 13:03:03 -0800 (PST)
Local: Mon, Dec 3 2007 4:03 pm
Subject: FDA APPROVAL Diovan
Reply to author | Forward | Print | Individual message | Report this message | Find messages by this author

    Reply to author    Forward  
You must Sign in before you can post messages.
To post a message you must first join this group.
Please update your nickname on the subscription settings page before posting.
You do not have the permission required to post.
ortiz.i...@gmail.com  
View profile  
 More options Dec 23 2007, 6:55 am
From: ortiz.i...@gmail.com
Date: Sun, 23 Dec 2007 03:55:32 -0800 (PST)
Local: Sun, Dec 23 2007 6:55 am
Subject: Re: FDA APPROVAL Diovan
Reply to author | Forward | Print | Individual message | Report this message | Find messages by this author
I definitely will say that with the approval of Diovan is a positive
hit for NVS; this will balance the slowing sales in USA market. By the
other hand the European Union market seem that has more troubles than
the USA market and caused a down grate to most of the lager capital
value stocks.

Given those two situations and the NVS reorganization, I will expect
that NVS will raise aging in the second quarter of 2008.

IOB Advisor


    Reply to author    Forward  
You must Sign in before you can post messages.
To post a message you must first join this group.
Please update your nickname on the subscription settings page before posting.
You do not have the permission required to post.
novartisconce...@gmail.com  
View profile  
 More options Dec 25 2007, 6:55 pm
From: novartisconce...@gmail.com
Date: Tue, 25 Dec 2007 15:55:29 -0800 (PST)
Local: Tues, Dec 25 2007 6:55 pm
Subject: Re: FDA APPROVAL Diovan
Reply to author | Forward | Print | Individual message | Report this message | Find messages by this author
maybe positive but could there be other concerns?  novartis is cutting
5% of global workforce.


    Reply to author    Forward  
You must Sign in before you can post messages.
To post a message you must first join this group.
Please update your nickname on the subscription settings page before posting.
You do not have the permission required to post.
investorss...@gmail.com  
View profile  
 More options Jan 2 2008, 12:44 pm
From: investorss...@gmail.com
Date: Wed, 2 Jan 2008 09:44:20 -0800 (PST)
Local: Wed, Jan 2 2008 12:44 pm
Subject: Re: FDA APPROVAL Diovan
Reply to author | Forward | Print | Individual message | Report this message | Find messages by this author

    Reply to author    Forward  
You must Sign in before you can post messages.
To post a message you must first join this group.
Please update your nickname on the subscription settings page before posting.
You do not have the permission required to post.

End of messages  

« Newer discussion  -  The market turns defensive   Is it time to sell Novartis?  -  Older discussion »




Google Home - Terms of Service - Privacy Policy

©2009 Google